OD-OS, the global leader in the development and commercialization of navigated retinal laser systems, today announced the release of the latest major update for Navilas 577s.

The update, which is provided free-of-charge to all Navilas 577s users, greatly accelerates the speed at which laser spots are delivered.  As a result, treatment times for both the newly introduced pre-planned peripheral treatment option (pp-PRP) and navigated microsecond pulsed treatments are markedly reduced.  In addition to making treatments faster, the update also improves laser uptake evaluation and the overall user experience.

The new, faster pre-planned PRP can be seen in action in this preview video: https://www.od-os.com/navilas-rapid-prp/

“After the very successful launch of Navilas 577s last October and its rapidly growing adoption, the Navilas technology is well on its way to replace conventional slit-lamp based pattern lasers”, says Navilas Product Manager Wolfgang Kern, “Recent improvements also make navigated laser the easiest-to-perform retinal laser procedure, especially for novice users.  By allowing physicians to pre-plan the treatment, rather than wasting time on pattern positioning, we give them the ability to invest more time into better patient care.”  Mr. Kern went on to add, “We continuously collect feedback and suggestions from our valued customers.  This feedback is directly incorporated into every update to improve our user’s day-to-day clinical experience.  Additionally, an update for our Navilas 577+ system is scheduled to be released within the quarter.“

Navilas 577s enables physicians to digitally pre-plan the entire laser therapy on fundus images as well as on third-party diagnostic images, and to precisely execute this therapy plan under computer guidance. Unlike any other retina laser, Navilas offers focal treatments without a contact lens and infrared illumination for unsurpassed patient comfort.  A large field of view and assisted pattern positioning greatly improve speed in panretinal and focal treatments.

Indications for use: Navilas® Laser System 577s and the Navilas Laser System 577+ are retinal photocoagulators integrated with a digital fundus camera. They are indicated for use in
•    Retinal Photocoagulation for the treatment of Clinically Significant Diabetic Macular Edema (Focal or Grid Laser), Proliferative Diabetic Retinopathy (Panretinal Photocoagulation), Sub-retinal (Choroidal) Neovascularization (Focal Laser), Central and Branch Retinal Vein Occlusion (Scatter Laser Photocoagulation, Focal or Grid Laser), Lattice Degeneration, Retinal Tears and Detachments (Laser Retinopexy).
•    Imaging (capture, display, storage and manipulation) of the retina of the eye, including color and infrared imaging; and for aiding in the diagnosis and treatment of ocular pathology in the posterior segment of the eye.

OD-OS is the first and only company to develop and commercialize Navigated Laser treatments in Ophthalmology.

About OD-OS:     OD-OS, Inc., a privately-held medical device company founded in 2008 with offices in Teltow, Germany and Irvine, Calif., is dedicated to the development and commercialization of advanced navigated imaging and laser treatment technology used to facilitate the advanced treatment of retinal eye diseases, many of which may lead to permanent blindness. Visit www.od-os.com for more details.

For further information, please contact:

Dr. Erik Blazek, Director Marketing | erik.blazek@od-os.com, +49 (172) 324 90 31
OD-OS GmbH | Warthestr. 21 | 14513 Teltow | Germany | Phone.: +49 (3328) 312 82 100
info@od-os.com | www.od-os.com